1. Popiel-Kopaczyk, A., Grzegrzolka, J., Piotrowska, A., Olbromski, M., Smolarz, B., Romanowicz, H.,
Rusak, A., Mrozowska, M., Dziegiel, P., Podhorska-Okolow, M., et al. (2023). The Expression of Testin,
Ki-67 and p16 in Cervical Cancer Diagnostics. CIMB 45, 490–500.
2. Gatius, S.; Jove, M.; Megino-Luque, C.; Albertí-Valls, M.; Yeramian, A.; Bonifaci, N.; Piñol, M.;
Santacana, M.; Pradas, I.; Llobet-Navas, D.; Pamplona, R.; Matías-Guiu, X.; Eritja, N. (2022).
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as
Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer. Cancers, 14 (12), 2842.
3. Flanagan, D. J.; Amirkhah, R.; Vincent, D. F.; Gundaz, N.; Gentaz, P.; Cammareri, P.; McCooey, A. J.;
McCorry, A. M. B.; Fisher, N. C.; Davis, H. L.; Ridgway, R. A.; Lohuis, J.; Leach, J. D. G.; Jackstadt,
R.; Gilroy, K.; Mariella, E.; Nixon, C.; Clark, W.; Hedley, A.; Markert, E. K.; Strathdee, D.;
Bartholin, L.; Redmond, K. L.; Kerr, E. M.; Longley, D. B.; Ginty, F.; Cho, S.; Coleman, H. G.;
Loughrey, M. B.; Bardelli, A.; Maughan, T. S.; Campbell, A. D.; Lawler, M.; Leedham, S. J.; Barry, S.
T.; Inman, G. J.; van Rheenen, J.; Dunne, P. D.; Sansom, O. J. (2022). Epithelial TGFβ Engages
Growth-Factor Signalling to Circumvent Apoptosis and Drive Intestinal Tumourigenesis with Aggressive
Features. Nat Commun, 13 (1), 7551.
4. Farkash, S.; Schwartz, N.; Edison, N.; Greenberg, S.; Peled, H. B.; Sindiany, W.; Krausz, J. (2022).
Tissue Microarrey: A Potential Cost-Effective Approach for Mismatch Repair Testing in Colorectal Cancer.
BMC Gastroenterol, 22 (1), 504.
5. Ugolini, F.; Szumera-Ciećkiewicz, A.; Baroni, G.; Nesi, G.; Mandalà, M.; Ferrone, S.; Massi, D.
(2022). Differential HLA Class I Subunit (A, B, C Heavy Chain and Β2-Microglobulin) Expression Levels in
Normal Tissues. Virchows Arch.
6. Benhamou, S., Fournier, E., Puppa, G., McKee, T., Ris, F., Rubbia, L., Viassolo, V., Zilli, T.,
Zlobec, I., Chappuis, P.O., et al. (2022). Cohort profile: population-b¬ ased cohorts of patients with
colorectal cancer and of their relatives in Geneva, Switzerland. Open access, 9.
7. Ferician, A.M., Ferician, O.C., Cumpanas, A.D., Berzava, P.L., Nesiu, A., Barmayoun, A., and Cimpean,
A.M. (2022). Heterogeneity of Platelet Derived Growth Factor Pathway Gene Expression Profile Defines
Three Distinct Subgroups of Renal Cell Carcinomas. Cancer Genomics Proteomics 19, 477–489.
8. Partynska, A., Gomulkiewicz, A., Piotrowska, A., Grzegrzolka, J., Rzechonek, A., Ratajczak-Wielgomas,
K., Podhorska-Okolow, M., and Dziegiel, P. (2022). Expression of Zyxin in Non-Small Cell Lung Cancer—A
Preliminary Study. Biomolecules 12, 827.
9. Ratajczak-Wielgomas, K., Kmiecik, A., and Dziegiel, P. (2022). Role of Periostin Expression in
Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells
via Regulation of MMP-2 Expression. IJMS 23, 1240.
10. Iaccarino, A., Acanfora, G., Pisapia, P., Malapelle, U., Bellevicine, C., Troncone, G., and Vigliar,
E. (2022). Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the
Predictive Pathology Era: The PD-L1 Experience. JMP 3, 15–23.
11. Hladek, L., Bankov, K., von der Grün, J., Filmann, N., Demes, M., Vallo, S., Wild, P.J., and
Winkelmann, R. (2022). Tumor-associated immune cell infiltrate density in penile squamous cell
carcinomas. Virchows Arch.
12. Wozniak, S., Nowinska, K., Chabowski, M., and Dziegiel, P. (2022). Significance of Irisin (FNDC5)
Expression in Colorectal Cancer. In Vivo 36, 180–188.
2021
13. Haslbauer, J.D., Stalder, A., Zinner, C., Bassetti, S., Mertz, K.D., Went, P., Matter, M., and
Tzankov, A. (2021). Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and
Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Pathobiology, 1–12.
14. Carpenco, E., Fulga, V., David, V., Foca, E., Saptefrati, L., (2021) Mast cells in luminal vs
non-luminal breast cancers E. Carpenco et al. Moldovan Medical Journal
15. Rubisz, P., Hirnle, L., and Kobierzycki, C. (2021) The Immunohistochemical Expression of MCM-3, -5,
and -7 Proteins in the Uterine Fibroids Curr. Issues Mol. Biol.
16. Meriläinen, A-S., Sihto, H., and Koljonen, V. (2021) Merkel cell polyomavirus is a passenger virus in
both poroma and porocarcinoma J Cutan Pathol.
17. Kaprio, H., Heuser, V. D., Orte, K., Tukiainen, M., Leivo, I., and Gardberg, M. (2021) Expression of
Transcription Factor CREM in Human Tissues Journal of Histochemistry & Cytochemistry
18. Strohmeier, S., Brcic, I., Popper, H., Liegl-Atzwanger, B., Lindenmann, J., and Brcic, L. (2021)
Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
Scientific Reports
19. Viborg Lindskrog, S., Prip, F., […] and Dyrskjot, L. (2021) An integrated multi-omics analysis
identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer Nature Communications
20. Lee, C-J., Wozniak, A., Van Cann, T., Timmermans, I., Wellens, J., Vanleeuw, U., Briaire-de Bruijn,
I. H., Britschgi, C., Bovée, J. V. M. G., Zlobec, I., Sciot, R. and Schöffski, P. (2021) Establishment
of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research Sarcoma
21. Zadka, L., Chabowski, M., Grybowski, D., Piotrowska, A., and Dziegiel, P. (2021) Interplay of stromal
tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts,
clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer
Cancer Immunology, Immunotherapy
22. Weber, M., Homm, A., Müller, S., Frey, S., Amann, K., Ries, J., Geppert, C., Preidl, R., Möst, T.,
Kämmerer, P. W., Kesting, M. and Wehrhan, F. (2021) Zoledronate Causes a Systemic Shift of Macrophage
Polarization towards M1 In Vivo International Journal of Medical Sciences 2020
23. Remoué, A., Conan-Charlet, V., Deiana, L., Tyulyandina, A., Marcorelles, P., Schick, U., and Uguen,
A. (2020) Breast cancer tumor heterogeneity has only little impact on the estimation of Oncotype DX®
recurrence score using Magee equations and Magee Decision Algorithm Human Pathology
24. Grzegrzolka, J., Olbromski, M., Gomulkiewicz, A., Piotrowska, A., Glatzel Plucinska, N., Ratajczak,
K., Sputa Grzegrzolka, P., Rzechonek, A., Werynska, B., Podhorska Okolow, M., and Dziegiel, P. (2020)
Role of tesmin expression in non small cell lung cancer Oncology Letters
25. Ciesielska, U., Piotrowska, A., Kobierzycki, C., Pastuszewski, W., Podhorska-Okolow, M., Dziegiel, P.
and Nowinska, K. (2020) Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of
Proliferative Markers Expression in Laryngeal Squamous Cell Cancer in vivo
26. Gowkielewicz, M., Lipka, A., Majewska, M., Piotrowska, A., Szadurska-Noga, M., Nowakowski, J. J.,
Wiszpolska, M., Dziegiel, P., Wasniewski, T., Majewski, M. K. and Jozwik, M. (2020) Anti-Müllerian
Hormone Type II Receptor Expression in Endometrial Cancer Tissue Cells
27. Carpenco, E. (2020) S100 protein in molecular subtypes of breast cancer Moldovan Medical Journal
28. Margan, M. M., Cimpean, A. M., Ceausu, A R., and Raica, M., (2020) Differential Expression of
E-Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes Anticancer Research
29. Lehmann, M., Marklund, M., Bolender, A-L., Bidhendi, E. E., Zetterström, P., Andersen, P. M.,
Brännström, T., Marklund, S. L., Gilthorpe, J. D. and Nordström, U. (2020) Aggregate-selective antibody
attenuates seeded aggregation but not spontaneously evolving disease in SOD1 ALS model mice Acta
Neuropathologica Communications
30. Deman, F., Punie, K., Laenen, A., Neven, P., Oldenburger, E., Smeets, A., Nevelsteen, I., Van
Ongeval, C., Baten, A., Faes, T., Christiaens, M., Janssen, H., Weltens, C., Desmedt, C., Wildiers, H.
and Floris, G. (2020) Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical
features in invasive micropapillary breast carcinoma with long-term outcomes Epidemiology
31. Luksza, M., Balachandran, V. P., Levin, A. J., Wolchok, J. D., Merghoub, T., Leach, S. D., Chan, T.
A., Greenbaum, B. D., and Laessig, M. (2020) Neoantigens and uses thereof for treating cancer (United
States Patent Application 20200232040) Free Patents Online
32. Contat, C., Ancey, P-B., Zangger, N., Sabatino, S., Pascual, J., Escrig, S., Jansen, L., Goepfert,
C., Lanz, B. et al (2020) Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth eLife
Sciences
33. Somri-Gannam, L., Meisel-Sharon, S., Hantisteanu, S., Groisman, G., Limonad, O., Hallak, M., and
Bruchim, I. (2020) IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer
Science Direct
34. Tanaka, A., Zhou, Y., Ogawa, M., Shia, J., Klimstra, D. S., Wang, J. Y., Roehrl, M. H. (2020) STAT1
as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite
instability PLOS One
35. Tian, C., Öhlund, D., Rickelt, S., Lidström, T., Huang, Y., Hao, L., Zhao, R. T., Franklin, O.,
Bhatia, S. N., Tuveson, D. A., Hynes, R. O. (2020) Cancer-cell derived matrisome proteins promote
metastasis in pancreatic ductal adenocarcinoma Cancer Research
お問い合わせいただきありがとうございます